Apollo becomes first hospital in India to use tubeless VATS technique to treat cancer

"We have successfully done India's first same sitting bilateral VATS for our patient from Bangladesh," said Dr. Abhijit Das, Consultant Thoracic Oncologist, Apollo Hospitals.

Published On 2021-02-16 03:30 GMT   |   Update On 2021-02-16 03:30 GMT

Chennai: For the first time in India, new tubeless video-assisted thoracoscopic surgery (VATS) technique was used to successfully treat lung cancer patients from Bangladesh.

Also Read:Medical negligence attributed to non-involvement of Specialists: Hospital, Doctors directed to pay Rs 10 lakh compensation

Doctors from Apollo Cancer Centre performed the surgery and confirmed the recovery of the patient.

"We have successfully done India's first same sitting bilateral VATS for our patient from Bangladesh," said Dr. Abhijit Das, Consultant Thoracic Oncologist, Apollo Hospitals.

Also Read:New class of drug leads to 30% reduced risk of death for bladder cancer patients

Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News